EMERALD ADVISERS, LLC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$19,314,713
-44.7%
1,473,281
+7.8%
0.94%
-38.8%
Q2 2023$34,945,810
+1.7%
1,366,138
+0.2%
1.53%
-7.2%
Q1 2023$34,345,381
+25.7%
1,363,453
+14.7%
1.65%
+24.8%
Q4 2022$27,317,776
+10.4%
1,188,246
+6.0%
1.32%
+3.4%
Q3 2022$24,735,000
+61.4%
1,120,765
+4.9%
1.28%
+61.9%
Q2 2022$15,328,000
-7.1%
1,068,884
+22.5%
0.79%
+25.3%
Q1 2022$16,495,000
+133.5%
872,279
+130.2%
0.63%
+141.0%
Q4 2021$7,063,000
-3.4%
378,928
+39.4%
0.26%
-1.9%
Q3 2021$7,313,000
-13.5%
271,877
+0.5%
0.27%
-13.6%
Q2 2021$8,453,000270,4070.31%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,907,823$25,011,5602.31%
FORMULA GROWTH LTD 222,269$2,913,9470.99%
EMERALD MUTUAL FUND ADVISERS TRUST 1,193,939$15,652,5400.94%
EMERALD ADVISERS, LLC 1,473,281$19,314,7130.94%
Perceptive Advisors 1,834,060$24,044,5270.80%
NEXT CENTURY GROWTH INVESTORS LLC 512,738$6,721,9950.73%
OBERWEIS ASSET MANAGEMENT INC/ 355,600$4,661,9160.50%
Novo Holdings A/S 360,000$4,719,6000.35%
TimesSquare Capital Management, LLC 1,433,429$18,7920.29%
KORNITZER CAPITAL MANAGEMENT INC /KS 677,733$8,885,0800.18%
View complete list of TREACE MED CONCEPTS INC shareholders